Switch to:
More From Other Websites
Alkermes' Pipeline Development Impresses, Key Updates Ahead Jul 21 2014
Alkermes Announces Initiation of Phase 1 Clinical Study of ALKS 8700 for Treatment of Multiple... Jul 17 2014
Alkermes announces initiation of Phase 1 study of ALKS 8700 for treatment of MS Jul 17 2014
Alkermes Announces Initiation of Phase 1 Clinical Study of ALKS 8700 for Treatment of Multiple... Jul 17 2014
Alkermes Announces Notices of Allowance for U.S. Patents for Four CNS Pipeline Candidates Jul 09 2014
Alkermes Announces Notices of Allowance for U.S. Patents for Four CNS Pipeline Candidates Jul 09 2014
Momentum names slammed as volatility comes back Jul 08 2014
Alkermes plc (ALKS) Jumps: Stock Rises 5.7% Jun 23 2014
Alkermes' Aripiprazole Lauroxil Looks Promising Jun 19 2014
New Alkermes Schizophrenia Drug -- An Important Advance With Social Benefits Jun 18 2014
Alkermes presents aripiprazole lauroxil phase 3 data Jun 18 2014
Alkermes Progresses with its Late Stage Candidate Jun 11 2014
Alkermes announces initiation of FORWARD-3, FORWARD-4 efficacy studies Jun 10 2014
Alkermes Announces Initiation of FORWARD-3 and FORWARD-4 Efficacy Studies in Pivotal Program for... Jun 10 2014
Alkermes Announces Initiation of FORWARD-3 and FORWARD-4 Efficacy Studies in Pivotal Program for... Jun 10 2014
What's in a Name? Alkermes Thinks Alkeus is too Close for Comfort Jun 09 2014
Alkermes' Pipeline Holds Promise Jun 06 2014
Sanofi, Alkermes Name, Pandora: Intellectual Property Jun 04 2014


Add Notes, Comments or Ask Questions

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide